OcellO

    OverviewSuggest Edit

    OcellO is a biotech company offering research services for the drug discovery industry. It provides compound screening using organoids and primary human 3D cultures of cancer cells, immune cell co-cultures, and polycystic kidney disease cells.
    TypePrivate
    Founded2011
    HQLeiden, NL
    Websiteocello.nl

    Latest Updates

    Employees (est.) (Nov 2021)28(-6%)
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    OcellO Office Locations

    OcellO has an office in Leiden
    Leiden, NL (HQ)
    J.H. Oortweg 21, j h
    Show all (1)

    OcellO Financials and Metrics

    Summary Metrics

    Founding Date

    2011

    OcellO Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    99/100

    SecurityScorecard logo

    OcellO Online and Social Media Presence

    Embed Graph

    OcellO Blogs

    CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings

    CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings Acquisition augments CrownBio’s preclinical in vitro service platforms, adding high content imaging and advanced tumor organoid analytics to three-dimensional immuno-oncology drug assays San Diego, Ca…

    3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors

    3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors Our recent paper investigating the effects of Tankyrase inhibitors on colorectal cancer  organoids shows how imagea nalysis reveals subtle alterations consistent with effects on stem cell subpopulations. This work…

    Join the upcoming ”Drug Discovery Powered by HUB organoids and OcellO 3D Image Analysis” webinar

    The post Join the upcoming ”Drug Discovery Powered by HUB organoids and OcellO 3D Image Analysis” webinar appeared first on OcellO B.V..

    OcellO will be presenting at the 32nd EORTC-NCI-AACR virtual Symposium taking place on the 24th of October, 2020

    The post OcellO will be presenting at the 32nd EORTC-NCI-AACR virtual Symposium taking place on the 24th of October, 2020 appeared first on OcellO B.V..

    Webinar on “Drug Discovery Powered by HUB organoids and OcellO 3D Image Analysis” – 26.10.20

    We like to invite you to “Drug Discovery Powered by HUB organoids and OcellO 3D Image Analysis” webinar OcellO has been working with organoids developed by the Hubrecht Organoid Technology since 2013 and provided compound screening and evaluation services to over 100 pharmaceutical and biotech comp…

    OcellO Frequently Asked Questions

    • When was OcellO founded?

      OcellO was founded in 2011.

    • How many employees does OcellO have?

      OcellO has 28 employees.

    • Who are OcellO competitors?

      Competitors of OcellO include SNBL, Chiltern and CellCarta.

    • Where is OcellO headquarters?

      OcellO headquarters is located at J.H. Oortweg 21, j h, Leiden.

    • Where are OcellO offices?

      OcellO has an office in Leiden.

    • How many offices does OcellO have?

      OcellO has 1 office.